Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001651308-25-000139
Filing Date
2025-09-09
Accepted
2025-09-09 17:31:54
Documents
1
Period of Report
2025-09-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1757453510.html 4  
1 FORM 4 wk-form4_1757453510.xml 4 7987
  Complete submission text file 0001651308-25-000139.txt   9675
Mailing Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051
Business Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051 41-616851900
BeOne Medicines Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MOLECULAR TEMPLATES, INC. 9301 AMBERGLEN BLVD, SUITE 100 AUSTIN VI 78729
Business Address
Sanders Corazon (Corsee) D. (Reporting) CIK: 0001796536 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 251304157